BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32204402)

  • 1. A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells.
    Deiana M; Dalle Carbonare L; Serena M; Cheri S; Mutascio S; Gandini A; Innamorati G; Lorenzi P; Cumerlato M; Bertacco J; Antoniazzi F; Romanelli MG; Mottes M; Zipeto D; Valenti MT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32204402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma.
    Cecconi D; Brandi J; Manfredi M; Serena M; Dalle Carbonare L; Deiana M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Avanzi F; Antoniazzi F; Marengo E; Tiso N; Mottes M; Zipeto D; Valenti MT
    Sci Rep; 2019 May; 9(1):8052. PubMed ID: 31142788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
    Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
    Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.
    Tandon M; Chen Z; Othman AH; Pratap J
    Oncogene; 2016 Sep; 35(36):4730-40. PubMed ID: 26804175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration.
    Deiana M; Dalle Carbonare L; Serena M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Manfredi M; Marengo E; Brandi J; Cecconi D; Mori A; Mina MM; Antoniazzi F; Mottes M; Tiso N; Malerba G; Zipeto D; Valenti MT
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization.
    Li XQ; Lu JT; Tan CC; Wang QS; Feng YM
    Cancer Lett; 2016 Sep; 380(1):78-86. PubMed ID: 27317874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.
    Akech J; Wixted JJ; Bedard K; van der Deen M; Hussain S; Guise TA; van Wijnen AJ; Stein JL; Languino LR; Altieri DC; Pratap J; Keller E; Stein GS; Lian JB
    Oncogene; 2010 Feb; 29(6):811-21. PubMed ID: 19915614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
    Villanueva F; Araya H; Briceño P; Varela N; Stevenson A; Jerez S; Tempio F; Chnaiderman J; Perez C; Villarroel M; Concha E; Khani F; Thaler R; Salazar-Onfray F; Stein GS; van Wijnen AJ; Galindo M
    J Cell Physiol; 2019 Aug; 234(8):13659-13679. PubMed ID: 30637720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression.
    Dalle Carbonare L; Minoia A; Vareschi A; Piritore FC; Zouari S; Gandini A; Meneghel M; Elia R; Lorenzi P; Antoniazzi F; Pessoa J; Zipeto D; Romanelli MG; Guardavaccaro D; Valenti MT
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
    Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma cell-derived Runx2 promotes myeloma progression in bone.
    Trotter TN; Li M; Pan Q; Peker D; Rowan PD; Li J; Zhan F; Suva LJ; Javed A; Yang Y
    Blood; 2015 Jun; 125(23):3598-608. PubMed ID: 25862559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
    Tandon M; Chen Z; Pratap J
    J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
    Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
    J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.
    Boregowda RK; Olabisi OO; Abushahba W; Jeong BS; Haenssen KK; Chen W; Chekmareva M; Lasfar A; Foran DJ; Goydos JS; Cohen-Solal KA
    Cancer Lett; 2014 Jun; 348(1-2):61-70. PubMed ID: 24657655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
    Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
    Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.
    Qiao M; Shapiro P; Fosbrink M; Rus H; Kumar R; Passaniti A
    J Biol Chem; 2006 Mar; 281(11):7118-28. PubMed ID: 16407259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.